Arthritis Cream - An Rx for FDA reform
An Rx for FDA reformBoston Globe - In 2004, Merck had to withdraw its blockbuster arthritis drug Vioxx after studies indicated it was associated with heart attacks and strokes These FDA failures are putting Congress to the test. It is working on bipartisan legislation that has the
Teen pulled from water trying to […]